Implementation of a Market Entry Reward within the United States

, , &
Journal of Law, Medicine and Ethics 46 (s1):50-58 (2018)
  Copy   BIBTEX

Abstract

As part of a multifactorial approach to address weak incentives for innovative antimicrobial drug development, market entry rewards are an emerging solution. Recently, the Duke-Margolis Center for Health Policy released the Priority Antimicrobial Value and Entry Award proposal, which combines a MER with payment reforms, transitioning from volume-based to “value-based” payments for antimicrobials. Here, the PAVE Award and similar MERs are reviewed, focusing on further refinement and avenues for implementation.

Categories

Add categories

Keywords

Reprint years

DOI

10.1177/1073110518782915

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,774

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Simulating Market Entry Rewards for Antibiotics Development.Christopher Okhravi, Simone Callegari, Steve McKeever, Carl Kronlid, Enrico Baraldi, Olof Lindahl & Francesco Ciabuschi - 2018 - Journal of Law, Medicine and Ethics 46 (s1):32-42.
Transferable Exclusivity Vouchers and Incentives for Antimicrobial Development in the European Union.Victor L. Van de Wiele, Adam Raymakers, Aaron S. Kesselheim & Benjamin N. Rome - 2023 - Journal of Law, Medicine and Ethics 51 (1):213-216.
Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D.Andrea Morales Caceres, Kshitij Kumar Singh, Timo Minssen, Susan Rogers Van Katwyk & Steven J. Hoffman - 2022 - Journal of Law, Medicine and Ethics 50 (S2):47-54.
The Effects of Market Structure and Payment Rate on the Entry of Private Health Plans into the Medicare Market.Austin B. Frakt, Steven D. Pizer & Roger Feldman - 2012 - Inquiry: The Journal of Health Care Organization, Provision, and Financing 49 (1):15-36.
Stimulating Research and Development of New Antibiotics While Ensuring Sustainable Use and Access: Further Insights from the DRIVE-AB Project and Others.Esther Bettiol, Judith Hackett & Stephan Harbarth - 2018 - Journal of Law, Medicine and Ethics 46 (s1):5-8.
Corruption of Pharmaceutical Markets: Addressing the Misalignment of Financial Incentives and Public Health.Marc-André Gagnon - 2013 - Journal of Law, Medicine and Ethics 41 (3):571-580.
Market Incentives and Health Care Reform.J. S. Taylor - 2008 - Journal of Medicine and Philosophy 33 (5):498-514.
Comparative Ethics of Modern Payment Models.Jacob Riegler - 2023 - Voices in Bioethics 9.
Cost-Sharing Reductions, Technocrat Tinkering, and Market-Based Health Policy.Allison K. Hoffman - 2018 - Journal of Law, Medicine and Ethics 46 (4):873-876.
Regulating the Global Antimicrobial Commons: Climate Agreements and Beyond.Philippe Cullet - 2023 - Health Care Analysis 31 (1):47-52.

Analytics

Added to PP
2018-07-20

Downloads
21 (#173,985)

6 months
6 (#1,472,471)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Add more citations

References found in this work

No references found.

Add more references